Table 5.
Effectiveness estimates | N (%) [95% CI] |
---|---|
Intention-to-treat analysis | |
Cured | 248 (98.8) [96.6–99.8] |
Patients in analysis | 251 |
Per protocol analysis 1* | |
Cured | 250 (99.6) [97.8–99.9] |
Patients in analysis | 251 |
Per protocol analysis 2* | |
Cured | 251 (100.0) [98.8–100.0]† |
Patients in analysis | 251 |
Intention-to-treat worst-case scenario analysis | |
Cured | 204 (81.3) [75.9–85.6] |
Patients in analysis | 251 |
Per protocol analysis 1 considered only relapses and kala-azar–related deaths as failures. Per protocol analysis 2 considered a single death for an unknown reason to be unrelated to kala-azar.
One-sided confidence interval.